Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 09-2014 | 03-2014 | 09-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,465 | 8,685 | 11,824 | 5,676 | 14,339 |
| Receivables | 236 | 253 | 261 | 152 | 135 |
| TOTAL | $6,792 | $9,071 | $12,186 | $5,967 | $14,575 |
| Non-Current Assets | |||||
| PPE Net | 17,314 | 20,909 | 19,545 | 16,873 | 11,394 |
| Intangibles | 9,942 | 15,103 | 15,479 | 15,034 | 19,230 |
| TOTAL | $27,256 | $36,012 | $35,024 | $31,907 | $30,624 |
| Total Assets | $34,047 | $45,083 | $47,210 | $37,874 | $45,199 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 120 | 287 | 123 | 52 | 74 |
| Accrued Expenses | 30 | 19 | 99 | 14 | 66 |
| TOTAL | $151 | $320 | $248 | $76 | $183 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $151 | $320 | $248 | $76 | $183 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 109,780 | 96,704 | 0 |
| Retained earnings | -65,920 | -64,332 | -66,005 | -61,520 | -48,159 |
| Other shareholders' equity | 1,798 | 1,981 | 3,186 | 2,614 | 2,578 |
| TOTAL | $33,896 | $44,762 | $46,962 | $37,798 | $45,016 |
| Total Liabilities And Equity | $34,047 | $45,083 | $47,210 | $37,874 | $45,199 |